Alaunos Therapeutics, Inc.
NASDAQ:TCRT
3.12 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0.005 | 2.922 | 0.398 | 0 | 0 | 0.146 | 6.389 | 6.861 | 4.332 | 1.373 | 0.8 | 0.8 | 0.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.002 |
| Kosten van de omzet
| 2.315 | 2.759 | 0.74 | 1.128 | 0.629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| -2.31 | 0.163 | -0.342 | -1.128 | -0.629 | 0.146 | 6.389 | 6.861 | 4.332 | 1.373 | 0.8 | 0.8 | 0.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.002 |
| Brutowinstmarge
| -462 | 0.056 | -0.859 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Onderzoek- en ontwikkelingskosten
| 16.279 | 25.018 | 49.643 | 52.696 | 38.331 | 34.134 | 45.084 | 157.791 | 106.785 | 32.706 | 42.852 | 83.446 | 57.083 | 12.91 | 4.556 | 17.245 | 18.993 | 10.391 | 5.594 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 12.219 | 13.142 | 27.564 | 27.665 | 19.527 | 19.918 | 14.798 | 14.377 | 17.647 | 12.166 | 15.661 | 19.523 | 14.984 | 11.636 | 7.567 | 8.374 | 0.773 | 8.72 | 0 | 0 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| -2.315 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.805 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 9.904 | 13.142 | 27.564 | 27.665 | 19.527 | 19.918 | 14.798 | 14.377 | 17.647 | 12.166 | 15.661 | 19.523 | 14.984 | 11.636 | 7.567 | 8.374 | 9.578 | 8.72 | 4.194 | 0.039 | 0.035 | 0 | 0 |
| Overige kosten
| 1.048 | 0.529 | -1.202 | 0.385 | 0.813 | 0.631 | 0.465 | 0.134 | 0.012 | -0.005 | -0.579 | -0.013 | 0 | 0 | 0 | 0 | 0 | 10.391 | 0 | 0 | 0 | 0.043 | 0.074 |
| Bedrijfskosten
| 26.183 | 38.16 | 77.207 | 80.361 | 57.858 | 54.052 | 59.882 | 172.168 | 124.432 | 44.872 | 58.513 | 102.969 | 72.067 | 24.546 | 12.123 | 25.619 | 28.57 | 19.112 | 9.787 | 0.039 | 0.036 | 0.043 | 0.074 |
| Bedrijfsresultaat
| -28.493 | -35.105 | -77.549 | -80.361 | 2.264 | -53.906 | -53.493 | -165.307 | -120.1 | -43.499 | -57.713 | -102.169 | -71.4 | -24.546 | -12.123 | -25.619 | -28.57 | -19.112 | -9.787 | -0.039 | -0.036 | -0.04 | -0.073 |
| Bedrijfsresultaat ratio
| -5,698.6 | -12.014 | -194.847 | 0 | 0 | -369.219 | -8.373 | -24.094 | -27.724 | -31.682 | -72.141 | -127.711 | -107.046 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.541 | -42.025 |
| Totaal overige inkomsten en kosten netto
| -6.647 | -2.625 | -1.202 | 0.385 | -120.06 | 0.789 | -0.83 | 0.01 | 0.012 | 11.718 | 0.606 | 6.037 | 7.622 | -8.124 | 4.474 | 0.388 | 0 | 1.255 | 0 | 0 | 0 | 0 | 0 |
| Inkomen voor belasting
| -35.14 | -37.73 | -78.751 | -79.976 | -117.796 | -53.117 | -54.323 | -165.297 | -120.088 | -31.781 | -57.107 | -96.132 | -63.778 | -32.67 | -7.649 | -25.231 | 0 | -17.857 | 0 | -0.039 | -0.036 | -0.04 | -0.073 |
| Inkomen voor belasting ratio
| -7,028 | -12.912 | -197.867 | 0 | 0 | -363.815 | -8.503 | -24.092 | -27.721 | -23.147 | -71.384 | -120.165 | -95.619 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.541 | -42.025 |
| Belastingkosten
| 2.147 | -0.133 | -1.857 | -1.128 | 60.122 | -0.947 | 2.125 | 0.114 | -0.012 | -23.441 | -1.791 | -12.087 | -15.244 | 16.248 | -8.948 | -0.388 | -1.962 | -1.255 | -0.27 | 0 | 0 | 0 | 0 |
| Nettowinst
| -35.14 | -37.597 | -76.894 | -78.848 | -177.918 | -53.117 | -54.323 | -165.297 | -120.088 | -31.781 | -57.107 | -96.132 | -63.778 | -32.67 | -7.649 | -25.231 | -26.608 | -17.857 | -9.517 | -0.039 | -0.036 | -0.04 | -0.073 |
| Nettowinstmarge
| -7,028 | -12.867 | -193.201 | 0 | 0 | -363.815 | -8.503 | -24.092 | -27.721 | -23.147 | -71.384 | -120.165 | -95.619 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.541 | -42.025 |
| WPA (Winst Per Aandeel)
| -2.2 | -2.6 | -5.38 | -5.64 | -15.89 | -0.37 | -0.4 | -1.27 | -0.96 | -0.31 | -0.66 | -1.22 | -0.97 | -0.71 | -0.33 | -1.19 | -1.41 | -1.42 | -2.32 | -0.65 | -18.31 | -0.36 | -0.8 |
| Verwaterde WPA
| -2.2 | -2.6 | -5.38 | -5.64 | -15.89 | -0.37 | -0.4 | -1.27 | -0.96 | -0.31 | -0.66 | -1.22 | -0.97 | -0.71 | -0.33 | -1.19 | -1.41 | -1.42 | -2.32 | -0.65 | -18.31 | -0.36 | -0.8 |
| EBITDA
| -26.178 | -34.709 | -76.069 | -80.361 | 2.893 | -54.064 | -52.198 | -165.183 | -120.1 | -55.222 | -58.16 | -107.561 | -78.754 | -16.234 | -16.597 | -25.231 | -28.137 | -18.938 | -9.686 | -0.039 | -0.035 | -0.039 | -0.072 |
| EBITDA ratio
| -5,235.6 | -11.879 | -191.128 | 0 | 0 | -370.301 | -8.17 | -24.076 | -27.724 | -40.22 | -72.7 | -134.451 | -118.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.23 | -41.59 |